Yasaman Setayeshpour at the bench with Jen-Tsan Ashley Chi (IMAGE)

Duke University

Yasaman Setayeshpour at the bench with Jen-Tsan Ashley Chi

Caption

Duke University School of Medicine researchers (left) Yasaman Setayeshpour, PhD, and Jen-Tsan Ashley Chi, PhD, are studying how a common class of cholesterol drugs, called fibrates, can strip away a key defense used by ovarian cancer cells, making them more vulnerable to treatment.

Credit

Duke University School of Medicine/Mark Dolejs

Usage Restrictions

Noncommercial use only.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.